Xbrane Biopharma AB (XBRANE) — Free Cash Flow Generation Index

Latest as of December 2024: 0.82x

Xbrane Biopharma AB (XBRANE) has a Free Cash Flow Generation Index of 0.82x as of December 2024. Free cash flow of Skr76.61 Million represents 1% of operating cash flow (Skr93.91 Million). Explore XBRANE capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.82x
Free Cash Flow / Operating CF

Free Cash Flow

Skr76.61 Million
SEK

Operating Cash Flow

Skr93.91 Million
SEK

Capital Expenditures

Skr17.30 Million
SEK

Xbrane Biopharma AB Free Cash Flow Generation Index (2018–2018)

Historical FCF Generation Index trend for Xbrane Biopharma AB across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Xbrane Biopharma AB.

Annual Free Cash Flow Generation for Xbrane Biopharma AB (2018–2018)

Year-by-year Free Cash Flow Generation Index for Xbrane Biopharma AB. Check cash flow reinvestment rate of Xbrane Biopharma AB to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (SEK) Operating CF Capital Expenditures YoY Change
2018 0.97x Skr45.11 Million Skr46.71 Million Skr1.60 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).